Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CONFERENCE CALL phone playback for 30 days by dialing (866) 281-6782. The access code for the replay is 167702.
LOOK AT THE FINANCIALS :))))) BRAVOOOOO...
JJSEABROOK To participate, please dial (800) 944-8766. The participant code for the call is 84358.
... I got his BB phone to listen the conference call... Scott H. Pearce CEO is talking now.... Kelly G. Maguire CFO will talk soon. He is a very smart guy like SABRi :))
JUST STARTED !!!!
OMW , SABRI is here next to me. We both joined the conference call. It is starting now.....
He is very excited eating his nails :D... He is from GAZIANTEP a great city, he is a day trader and full time hookah smoker....
http://www.barchart.com/quotes/stocks/BIOF !!! BIOF STRONG BUY... getting ready for 4th quarter numbers...
TOTAL ASSETS 344.1M
TOTAL LIABILITIES 153.6M
BIOFUEL ENERGY CORP BOOK VALUE = 190M or $1.57 PPS
TOTAL ASSETS 344.1M
TOTAL LIABILITIES 153.6M
BIOFUEL ENERGY CORP BOOK VALUE = 190M or $1.57 PPS
Scott H. Pearce, the Company’s
President and Chief Executive Officer. “As a result, our current expectations are that the
results for the fourth quarter of 2011 will now be even stronger than what we reported for
the third quarter.”
BIOF - projected earnings quote by CEO . And it is a quote from their site “Commodity margins have continued to strengthen and we continue to see the
benefits from our plant improvement projects,” said Scott H. Pearce, the Company’s
President and Chief Executive Officer. “As a result, our current expectations are that the
results for the fourth quarter of 2011 will now be even stronger than what we reported for
the third quarter.”
$BIOF -- Report out tomorrow after the bell. Get in before then!
I like the book value on BIOF . We are now @.745. The other thing is BIOF has a positive cash flow. PEIX is always diluting shares to raise funds . Let's hope for a good report on thursday for BIOF. As of now, we are the unwanted step child. BIOF outperforms PEIX historically as well... DD !!!!
BIOFUEL ENERGY CORP. (NASDAQ: BIOF) announced that it will be releasing its fourth quarter and year-end 2011 earnings on Thursday, March 1, 2012, after the market closes.
The Company plans to host a conference call on Friday, March 2, 2012, beginning at 11:00 a.m. (EST) to discuss the results. To participate, please dial (800) 944-8766. The participant code for the call is 84358. This call will be available for phone playback for 30 days by dialing (866) 281-6782. The access code for the replay is 167702.
BIOF:
Total Cash (mrq): 9.66M
Total Cash Per Share (mrq): 0.09
Total Debt (mrq): 188.27M
Total Debt/Equity (mrq): 198.01
Current Ratio (mrq): 1.83
Book Value Per Share (mrq): 0.88
Cash Flow Statement
Operating Cash Flow (ttm): 15.19M
Levered Free Cash Flow (ttm): 20.67M
PLEASE DO READ GUYS !!!!
Where Does LiquidMetal & Gorilla Glass Fit Into the 2012 iPhone 5?
http://danbod.com/ArDF3H #iPhone5
I like this little $LQMT.OB rally today . iPad3 next month... iPhone5 _and_ new nano grist for the rumor mill. Fingers crossed it continues !!! hoppp
$LQMT up above 100ma - earnings out 3/15 - Bank of America acquires 5% of company. Looks like huge upside potential
earning almost in 3 weeks. ++LQMT huge volume today again. Liquid Metal use in iphone 5 is attracting buyers to name and come more I believe...
$lqmt pushing. Almost there. Long. !!! I am recommending all the investors to read latest 10Q.
Liquidmetal is going to be the third revolution in manufacturing.
great videoo explaining all
good luck the rest of guys on this board... I got my profits... don be greedy guys, shaky shaky remeber AM*I
I talked with SABRI.. he is buying big blocks for next week !!! Hope it is a good sign...
for you game over !!! The game is starting now...
Definite momentum here!!! Apple itself has grabbed the master LQMT license for consumer electronics…and Swatch is onboard in the luxury segment.
And in the here and now, LQMT’s shares are on the go:
After LQMT bottomed out at $0.1151 on December 16, price action is up a healthy 48%…pushing the stock from below the 10- to above the 50-day line!
RSI surged all the way from below 30 — “oversold” — to above 60 since the LQMT rally started.
Definite momentum here!!! Apple itself has grabbed the master LQMT license for consumer electronics…and Swatch is onboard in the luxury segment.
And in the here and now, LQMT’s shares are on the go:
After LQMT bottomed out at $0.1151 on December 16, price action is up a healthy 48%…pushing the stock from below the 10- to above the 50-day line!
RSI surged all the way from below 30 — “oversold” — to above 60 since the LQMT rally started.
LQMT.Definite momentum here!!! Apple itself has grabbed the master LQMT license for consumer electronics…and Swatch is onboard in the luxury segment.
And in the here and now, LQMT’s shares are on the go:
After LQMT bottomed out at $0.1151 on December 16, price action is up a healthy 48%…pushing the stock from below the 10- to above the 50-day line!
RSI surged all the way from below 30 — “oversold” — to above 60 since the LQMT rally started.
Definite momentum here!!! Apple itself has grabbed the master LQMT license for consumer electronics…and Swatch is onboard in the luxury segment.
And in the here and now, LQMT’s shares are on the go:
After LQMT bottomed out at $0.1151 on December 16, price action is up a healthy 48%…pushing the stock from below the 10- to above the 50-day line!
RSI surged all the way from below 30 — “oversold” — to above 60 since the LQMT rally started.
LQMT Break Out list!!!!
I got LQMT DD from SABRI last night.. he invested in this baby too.. looking forward to see him today in the afternoon
good consolidation on .20 .205 and .208 range... 1,5 M volume so far on 45 min in the market... do you have the level 2 screen to share with us RAY ??
LQMT... If we see the legendary trader Rayban34 !!! this will go to skyyyyy... mark my word !!
LQMT... If we see the legendary trader Rayban34 !!! this will go to skyyyyy... mark my word !!
MDRM up 5.27 % !!! .099 !!! ;))
MDRM up 5.27 % !!! .0999 !!! ;))
Good Morning MDRMs !!! Bounce back game is onnnnn
MDRM - Should see continued accumulation at this level before this makes a push up, IMO.
Agree... accumulating more from .11 and .12s then boom !!!
HUGE BREAKOUT !!!! BIG NEWSSS BOOYAHHH
MDRM - Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
Modern Mobility Aids (OTCBB:MDRM)
Today : Wednesday 23 November 2011
Modern Mobility Aids, Inc. (OTCBB: MDRM) (the "Company") is pleased to announce that it has confirmed the financing required to execute its closing agreement to acquire all of the common stock of LumiGene Technologies, Inc. ("LumiGene").
Modern Mobility Aids, Inc. is a Nevada-based Company whose strategic focus lies within innovative research and development in the Bio-Pharma sector as well as scalable manufacturing in niche markets in the Bio-Pharma sector. The company seeks to acquire companies within the Bio-Pharma sector, targeting innovative research and development as well as scalable manufacturing capacity in three niche market segments: CRAM –Contract Research and Manufacturing for Life Sciences Companies, HEALTHCARE INNOVATION – Novel Drug and Device Delivery Format Packaging and BIOPHARMA PARTNERSHIPS – Strategic Development and Production Alliances
First Capital Invest Corp., (FCIC) a company incorporated under the laws of British Virgin Islands and having its office located in Zollikon, Switzerland, has agreed to provide financing to MDRM to facilitate the November 30, 2011 closing of its acquisition of all the common stock of LumiGene Technologies.
The term of FCIC's engagement with MDRM shall commence effective November 22, 2011 and shall provide a term of one year after each draw. FCIC has committed to providing operating funds in the sum of US $1,500,000 (One Million, five hundred thousand), with an initial draw of $500,000 US before November 28, 2011. In addition, it has facilities for additional draws of US $250,000 each month thereafter, as required, up to the maximum of $1,500,000.
LumiGene is a Canadian molecular diagnostics company developing point-of-care products which will enable healthcare professionals to quickly and effectively diagnose and treat infectious diseases. Through the development and commercializing of its POSiChek™ System for the near sample/point-of-care DNA diagnostic markets, LumiGene expects to address the current needs that are in high demand by healthcare professionals worldwide.
"It is refreshing to see that our vision for MDRM is supported so well by FCIC, who are truly industry professionals that understand the impact of what MDRM is undertaking, and we see nothing but positive results as we continue to flesh out our strategy," Mohamed K. Karatella, President and CEO for MDRM, stated. He went on to state that: "Our finalization of the LumiGene acquisition solidifies LumiGene's ongoing pursuit to be the first to market with a greatly needed new technology that we expect will be in high demand. We look forward to working with the talented team at LumiGene."
About Modern Mobility Aids, Inc.
Modern Mobility Aids, Inc. has recently revamped its corporate infrastructure and now plans to direct its focus and energies on the multibillion dollar pharmaceutical and biotechnology industries. Through the formation of their new business model, the Company expects to implement an aggressive campaign in order to seek out and research companies from early developmental stages to mezzanine levels in the research and development, manufacturing and distribution markets, within the pharmaceutical and biotechnology industry. The Company is confident that strategic acquisitions and first stage investments will play a pivotal role in the Company's success in building a successful global entity.
The closing of this transaction is subject to various conditions including but not limited to the satisfactory completion of due diligence within 60 days. For more information pertaining to the specifics of the Definitive Agreement including the structure of the acquisition, please see the Company's most recent Current Report on Form 8-K which was recently filed with the U.S. Securities and Exchange Commission.
Safe Harbor
This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) financing plans; (ii) potential acquisitions, (iii) trends affecting its financial condition or results of operations; (iv) growth strategy and operating strategy. The words "may," "would," "will," "expect, "intend", "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in the Company's filings with the Securities and Exchange Commission.
Contact: Modern Mobility Aids, Inc. Public Relations and Shareholder Information:Email: investor@mdrmgroup.com
SOURCE Modern Mobility Aids, Inc.
MDRM READY TO RUN - GREAT NEWS !!! Morning Morning
MDRM - Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
Modern Mobility Aids (OTCBB:MDRM)
Today : Wednesday 23 November 2011
Modern Mobility Aids, Inc. (OTCBB: MDRM) (the "Company") is pleased to announce that it has confirmed the financing required to execute its closing agreement to acquire all of the common stock of LumiGene Technologies, Inc. ("LumiGene").
Modern Mobility Aids, Inc. is a Nevada-based Company whose strategic focus lies within innovative research and development in the Bio-Pharma sector as well as scalable manufacturing in niche markets in the Bio-Pharma sector. The company seeks to acquire companies within the Bio-Pharma sector, targeting innovative research and development as well as scalable manufacturing capacity in three niche market segments: CRAM –Contract Research and Manufacturing for Life Sciences Companies, HEALTHCARE INNOVATION – Novel Drug and Device Delivery Format Packaging and BIOPHARMA PARTNERSHIPS – Strategic Development and Production Alliances
First Capital Invest Corp., (FCIC) a company incorporated under the laws of British Virgin Islands and having its office located in Zollikon, Switzerland, has agreed to provide financing to MDRM to facilitate the November 30, 2011 closing of its acquisition of all the common stock of LumiGene Technologies.
The term of FCIC's engagement with MDRM shall commence effective November 22, 2011 and shall provide a term of one year after each draw. FCIC has committed to providing operating funds in the sum of US $1,500,000 (One Million, five hundred thousand), with an initial draw of $500,000 US before November 28, 2011. In addition, it has facilities for additional draws of US $250,000 each month thereafter, as required, up to the maximum of $1,500,000.
LumiGene is a Canadian molecular diagnostics company developing point-of-care products which will enable healthcare professionals to quickly and effectively diagnose and treat infectious diseases. Through the development and commercializing of its POSiChek™ System for the near sample/point-of-care DNA diagnostic markets, LumiGene expects to address the current needs that are in high demand by healthcare professionals worldwide.
"It is refreshing to see that our vision for MDRM is supported so well by FCIC, who are truly industry professionals that understand the impact of what MDRM is undertaking, and we see nothing but positive results as we continue to flesh out our strategy," Mohamed K. Karatella, President and CEO for MDRM, stated. He went on to state that: "Our finalization of the LumiGene acquisition solidifies LumiGene's ongoing pursuit to be the first to market with a greatly needed new technology that we expect will be in high demand. We look forward to working with the talented team at LumiGene."
About Modern Mobility Aids, Inc.
Modern Mobility Aids, Inc. has recently revamped its corporate infrastructure and now plans to direct its focus and energies on the multibillion dollar pharmaceutical and biotechnology industries. Through the formation of their new business model, the Company expects to implement an aggressive campaign in order to seek out and research companies from early developmental stages to mezzanine levels in the research and development, manufacturing and distribution markets, within the pharmaceutical and biotechnology industry. The Company is confident that strategic acquisitions and first stage investments will play a pivotal role in the Company's success in building a successful global entity.
The closing of this transaction is subject to various conditions including but not limited to the satisfactory completion of due diligence within 60 days. For more information pertaining to the specifics of the Definitive Agreement including the structure of the acquisition, please see the Company's most recent Current Report on Form 8-K which was recently filed with the U.S. Securities and Exchange Commission.
Safe Harbor
This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) financing plans; (ii) potential acquisitions, (iii) trends affecting its financial condition or results of operations; (iv) growth strategy and operating strategy. The words "may," "would," "will," "expect, "intend", "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in the Company's filings with the Securities and Exchange Commission.
Contact: Modern Mobility Aids, Inc. Public Relations and Shareholder Information:Email: investor@mdrmgroup.com
SOURCE Modern Mobility Aids, Inc.